Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors

Journal of Infection

Volumn 60, Issue 3, 2010, Pages 191-199

  Jensen, Ulrich Stab ^a,b   Knudsen, Jenny Dahl ^b   Østergaard, Christian ^b   Gradel, Kim Oren ^c   Frimodt Møller, Niels ^a   Schønheyder, Henrik Carl ^c  

^a STATENS SERUM INSTITUT   (Denmark)

^b Copenhagen University Hospital ^*  (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CANDIDA; CHILD; COMORBIDITY; ENDOCARDITIS; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FUNGEMIA; GASTROINTESTINAL TRACT; GRAM NEGATIVE SEPSIS; GRAM POSITIVE INFECTION; HEPATOBILIARY SYSTEM; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; INTRAVENOUS CATHETER; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION BASED CASE CONTROL STUDY; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; RISK FACTOR; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CROSS INFECTION; DENMARK; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; YOUNG ADULT;

EID: 76849101392     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.12.007     Document Type: Article

References (39)

1. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
2. King M.D., Whitney C.G., Parekh F., Farley M. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis 2003, 37:1029-1036.
3. Turett G.S., Blum S., Telzak E.E. Recurrent pneumococcal bacteremia: risk factors and outcomes. Arch Intern Med 2001, 161:2141-2144.
4. Kreisel K., Boyd K., Langenberg P., Roghmann M.C. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn Microbiol Infect Dis 2006, 55:179-184. 10.1016/j.diagmicrobio.2006.01.021.
5. Fowler V.G., Kong L.K., Corey G.R., Gottlieb G.S., McClelland R.S., Sexton D.J., et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999, 179:1157-1161.
6. Galofre J., Moreno A., Mensa J., Miró J.M., Gatell J.M., Almela M., et al. Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia. Clin Infect Dis 1994, 18:873-878.
7. Hsu R.B., Chen R.J., Chu S.H. Risk factors for recurrent bacteremia in adult patients with nontyphoid salmonellosis. Am J Med Sci 2004, 328:315-318.
8. Sanz-Garcia M., Fernandez-Cruz A., Rodriguez-Creixems M., Cercenado E., Marin M., Munoz P., et al. Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors. Medicine (Baltimore) 2009, 88:77-82.
9. Mylotte J.M., McDermott C. Recurrent Gram-negative bacteremia. Am J Med 1988, 85:159-163. 10.1016/S0002-9343(88)80335-8.
10. Wendt C., Messer S.A., Hollis R.J., Pfaller M.A., Wenzel R.P., Herwaldt L.A. Recurrent Gram-negative bacteremia: incidence and clinical patterns. Clin Infect Dis 1999, 28:611-617.
11. Mora-Duarte J., Betts R., Rotstein C., Colombo A.L., Thompson-Moya L., Smietana J., et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002, 347:2020-2029.
12. Kontoyiannis D.P., Reddy B.T., Hanna H., Bodey G.P., Tarrand J., Raad Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity. Infect Control Hosp Epidemiol 2002, 23:542-545.
13. Einarsdottir H.M., Erlendsdottir H., Kristinsson K.G., Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect 2005, 11:744-7449.
14. Weinstein M.P., Murphy J.R., Reller L.B., Lichtenstein K.A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983, 5:54-70.
15. Roberts F.J. Definition of polymicrobial bacteremia. Rev Infect Dis 1989, 11:1029-1030.
16. Geerdes H.F., Ziegler D., Lode H., Hund M., Loehr A., Fangmann W., et al. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 1992, 15:991-1002.
17. Haug J.B., Harthug S., Kalager T., Digranes A., Solberg C.O. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis 1994, 19:246-256.
18. Pedersen G., Schønheyder H.C., Sørensen H.T. Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study. Scand J Infect Dis 1997, 29:601-606.
19. Roberts F.J., Geere I.W., Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991, 13:34-46.
20. Chang F.Y., Peacock J.E., Musher D.M., Triplett P., MacDonald P.P., Mylotte J.M., et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003, 82:333-339.
21. Pedersen C.B., Gøtzsche H., Møller JØ, Mortensen P.B. The Danish civil registration system. A cohort of eight million persons. Dan Med Bull 2006, 53:441-449.
22. Gradel K.O., Søgaard M., Dethlefsen C., Nielsen H., Schønheyder H.C. Magnitude of bacteraemia is a predictor of mortality during 1year of follow-up. Epidemiol Infect 2009, 137:94-101.
23. Schønheyder H.C., Højbjerg T. The impact of the first notification of positive blood cultures on antibiotic-therapy: a 1-year survey. APMIS 1995, 103:37-44.
24. Pedersen G., Schønheyder H.C., Sørensen H.T. Source of infection and other factors associated with case fatality in community-acquired bacteremia - a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect 2003, 9:793-802.
25. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 1988, 1988(16):128-140.
26. Friedman N.D., Kaye K.S., Stout J.E., McGerry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
27. Lesens O., Hansmann Y., Brannigan E., Hopkins S., Meyer P., O'Connel B., et al. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?. Infect Control Hosp Epidemiol 2005, 26:204-209.
28. DANMAP 2001 - Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Food and Humans in Denmark. Danish Zoonosis Centre 2002, 1600-2032. ISSN.
29. Justesen T., Korsager B., Scheibel J. Vej-ledning i brug af antibiotika. Lægeforeningens Medicinfortegnelse 1999, 827-851. Lægeforeningens forlag, Copenhagen. 22nd ed. J. Aldershvile, M.S. Hansen, J.P. Kampmann, B. Vej-Hansen (Eds.).
30. Wacholder S., Silverman D.T., McLaughlin J.K., Mandel J.S. Selection of controls in case-control studies: III. Design options. Am J Epidemiol 1992, 135:1042-1050.
31. Holmes B., Costas M., Thaker T., Stevens M. Evaluation of two BBL Crystal systems for identification of some clinically important gram-negative bacteria. J Clin Microbiol 1994, 32:2221-2224.
32. Manual of clinical microbiology 1999, ASM Press, Washington DC. 7th ed. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
33. Weinstein M.P., Reller L.B., Murphy J.R., Lichtenstein K.A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983, 5:35-53.
34. Pedersen G., Schønheyder H.C. Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis 1997, 29:169-173.
35. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
36. Capdevila J.A., Almirante B., Pahissa A., Planes A.M., Ribera E., Martinez-Vazquez J.M. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med 1994, 154:411-415.
37. Miller P.J., Farr B.M. Morbidity and mortality associated with multiple episodes of nosocomial bloodstream infection: a cohort study. Infect Control Hosp Epidemiol 1989, 10:216-219.
38. Jensen A.G., Wachmann C.H., Espersen F., Scheibel J., Skinhøj P., Frimodt-Møller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002, 162:25-32.
39. Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.